CCAR2 and neoplasm: The first documentation of SIRT1′s tumor promoter activity was demonstrated by its ability to deacetylate and inactivate tumor suppressors, such as p53, hypermethylated in cancer 1 (HIC1) and deleted in breast cancer 1 (DBC1) proteins [107,108,109].